Pulmonary Sarcoidosis: Symptoms, Diagnosis and Treatment

Pulmonary sarcoidosis: what it is and why early diagnosis matters

Pulmonary sarcoidosis is an inflammatory disease in which clusters of immune cells form small lumps called granulomas in the lungs and lymph nodes. It is the most common form of sarcoidosis, accounting for more than 90% of cases, and is a significant — yet often under-recognised — cause of chronic respiratory illness in India. At Pulmo Vista in Greater Kailash, New Delhi, patients with suspected pulmonary sarcoidosis receive a structured diagnostic workup and evidence-based management from a specialist pulmonologist with 10+ years of experience in respiratory and critical care.

  • Sarcoidosis is a systemic granulomatous disease — it can affect the lungs, lymph nodes, skin, eyes, and other organs.
  • The lungs are involved in over 90% of sarcoidosis cases.
  • The exact cause remains unknown; current evidence points to an abnormal immune response to an environmental or infectious trigger in genetically susceptible individuals.
  • In India, sarcoidosis is frequently misdiagnosed as tuberculosis due to overlapping clinical features.
  • Many patients with mild disease experience spontaneous remission; others require long-term treatment.
  • Early, accurate diagnosis is critical to preventing irreversible lung fibrosis.

Tip: Sarcoidosis and tuberculosis can look nearly identical on a chest X-ray. A specialist evaluation — including bronchoscopy or EBUS — is essential to distinguish between the two before starting any treatment.

Pulmonary sarcoidosis symptoms and how they present

Symptoms of pulmonary sarcoidosis vary widely — some patients are asymptomatic and diagnosed incidentally on a chest X-ray, while others present with significant respiratory impairment. Recognising the symptom pattern early allows timely intervention and reduces the risk of permanent lung damage.

Symptom Description Frequency
Dry persistent cough Non-productive cough lasting weeks to months Very common
Breathlessness (dyspnoea) Shortness of breath on exertion, worsening over time Very common
Chest tightness or pain Dull ache or pressure in the chest Common
Fatigue Persistent tiredness disproportionate to activity Common
Low-grade fever Mild fever, often mistaken for a viral illness or TB Moderate
Unintentional weight loss Gradual loss of weight without dietary change Moderate
Wheezing High-pitched breathing sound due to airway narrowing Less common

Extrapulmonary features — such as skin rashes (erythema nodosum), red eyes (uveitis), or swollen lymph nodes in the neck — may accompany lung symptoms and can provide important diagnostic clues. Patients experiencing these alongside respiratory symptoms should seek specialist pulmonology evaluation promptly.

Causes and risk factors for pulmonary sarcoidosis

The precise cause of pulmonary sarcoidosis is not fully established. Current evidence points to an abnormal immune response — likely triggered by an environmental, occupational, or microbial factor — in genetically susceptible individuals. The immune system forms granulomas in an attempt to wall off the perceived threat, and these granulomas accumulate in the lungs and lymph nodes.

  • Genetic predisposition: A family history of sarcoidosis increases individual risk.
  • Environmental exposures: Prolonged exposure to dust, moulds, or certain organic particles has been associated with sarcoidosis.
  • Occupational factors: Healthcare workers, firefighters, and agricultural workers may face higher exposure to triggering agents.
  • Microbial triggers: Some studies suggest mycobacterial or propionibacterial antigens may initiate the immune response — a factor particularly relevant in TB-endemic regions like India.
  • Age and sex: Sarcoidosis most commonly presents between the ages of 20 and 50 years; women may have a slightly higher incidence.

Patients with concurrent respiratory allergies or airway hypersensitivity can be assessed for overlapping conditions using allergy diagnosis and treatment services available at Pulmo Vista.

Warning: In India, the overlap between sarcoidosis and tuberculosis risk factors is significant. Starting anti-TB therapy without histological confirmation can delay correct diagnosis and cause harm. Always seek specialist evaluation before initiating treatment.

Sarcoidosis diagnosis: investigations and approach at Pulmo Vista

Diagnosing pulmonary sarcoidosis in India requires a combination of clinical assessment, imaging, lung function testing, and — in most cases — tissue confirmation. The challenge is that sarcoidosis mimics tuberculosis closely, and a systematic approach is essential to avoid misdiagnosis. At Pulmo Vista, advanced respiratory diagnostics are available under one roof, enabling faster and more accurate diagnosis.

  • Chest X-ray: First-line imaging; shows bilateral hilar lymphadenopathy (enlarged lymph nodes) in the majority of cases. Sarcoidosis is staged (Stage I–IV) based on X-ray findings.
  • High-Resolution CT (HRCT) of the chest: Provides detailed mapping of granuloma distribution, lymph node involvement, and any fibrotic changes.
  • Pulmonary Function Tests (PFT): Assess the degree of lung impairment. Pulmo Vista’s complete PFT system measures lung volumes, airflow, and diffusion capacity to track disease progression. Patients with airflow obstruction may also benefit from specialist COPD assessment to exclude concurrent disease.
  • Bronchoscopy with Bronchoalveolar Lavage (BAL): Samples cells from the airways; an elevated CD4:CD8 ratio in BAL fluid supports a sarcoidosis diagnosis.
  • Endobronchial Ultrasound (EBUS): A minimally invasive procedure that allows guided biopsy of mediastinal and hilar lymph nodes — the preferred method for tissue confirmation in pulmonary sarcoidosis. Pulmo Vista is skilled in EBUS-guided procedures.
  • Serum ACE (Angiotensin-Converting Enzyme): Elevated in many sarcoidosis patients; used as a supportive marker, not a standalone diagnostic test.
  • Tuberculin skin test / IGRA: Performed to exclude active tuberculosis before confirming sarcoidosis.
  • Lung Ultrasound: Used at Pulmo Vista for pleural assessment and USG-guided procedures where indicated.

Tissue biopsy showing non-caseating granulomas — with tuberculosis excluded — remains the diagnostic gold standard for sarcoidosis.

Pulmonary sarcoidosis treatment options and management plan

Not all patients with pulmonary sarcoidosis require immediate treatment. Management decisions are guided by disease stage, symptom severity, lung function impairment, and the presence of extrapulmonary involvement. The goal is to suppress granulomatous inflammation, preserve lung function, and prevent fibrosis.

Treatment Approach When Used Key Considerations
Watchful waiting (observation) Stage I–II with mild or no symptoms Regular monitoring with PFT and imaging; many cases remit spontaneously
Oral corticosteroids (Prednisolone) Symptomatic disease, declining lung function, Stage III–IV First-line pharmacological therapy; dose tapered over months; side effects monitored
Steroid-sparing agents (Methotrexate, Azathioprine) Steroid-dependent or steroid-intolerant patients Used as second-line agents; require regular blood monitoring
Inhaled corticosteroids Cough-predominant disease with airway involvement Adjunct therapy; less effective than systemic steroids for parenchymal disease
Pulmonary rehabilitation Chronic disease with functional impairment Improves exercise tolerance and quality of life; supported by specialist physiotherapy at Pulmo Vista

Treatment duration is typically 12–24 months for those requiring systemic therapy. Regular follow-up with pulmonary function tests and imaging is essential to assess treatment response and detect relapse early. Patients recovering from respiratory illness may also benefit from post-COVID physiotherapy if concurrent lung rehabilitation is needed.

When to see a pulmonologist for sarcoidosis symptoms

Seek evaluation from a pulmonologist promptly if you experience any of the following — do not wait for symptoms to resolve on their own, particularly in a TB-endemic setting like India where delayed diagnosis carries additional risks.

  • A dry cough persisting for more than 3 weeks without an identifiable cause such as a cold or allergy.
  • Breathlessness on mild exertion — such as climbing one flight of stairs — that was not present previously.
  • A chest X-ray report mentioning bilateral hilar lymphadenopathy or mediastinal widening.
  • Unexplained fatigue, low-grade fever, and weight loss lasting more than 2 weeks.
  • Skin lesions (particularly raised red nodules on the shins) or eye redness appearing alongside respiratory symptoms.
  • A diagnosis of sarcoidosis elsewhere that requires a second opinion, staging, or treatment planning.
  • Worsening symptoms despite being on treatment — indicating possible disease progression or need for regimen adjustment.

Tip: If you have been treated for tuberculosis but symptoms have not improved after 2 months of anti-TB therapy, ask your doctor to reconsider the diagnosis. Sarcoidosis is a recognised cause of treatment-resistant TB-like presentations in India.

Pulmonary sarcoidosis care at Pulmo Vista, Greater Kailash, New Delhi

Pulmo Vista, located at R45, Block R, Greater Kailash I, New Delhi — 110048, is a dedicated pulmonology clinic offering comprehensive respiratory care for conditions including pulmonary sarcoidosis. The clinic brings together advanced diagnostic technology and specialist expertise to support accurate diagnosis and personalised management.

  • EBUS (Endobronchial Ultrasound): Minimally invasive lymph node biopsy for tissue confirmation of sarcoidosis — avoiding the need for surgical procedures in most cases.
  • Complete Pulmonary Function Test (PFT) System: Measures lung volumes, airflow, and diffusion capacity to stage disease and monitor treatment response.
  • Forced Oscillation Technique (FOT): Non-invasive assessment of airway mechanics, particularly useful in patients who cannot perform standard spirometry.
  • Bronchoscopy: Airway visualisation and bronchoalveolar lavage for cellular analysis supporting sarcoidosis diagnosis.
  • Lung Ultrasound and USG-guided procedures: For pleural assessment and guided interventions where required.
  • 10+ years of experience in respiratory and critical care management, including lung granuloma diagnosis and treatment planning.
  • Patients with concurrent lung infections can access lung infection treatment within the same specialist team.

Book a consultation at Pulmo Vista

Use the booking form on this page, or reach out directly:

Call: 8448046304

WhatsApp: 8448046304

Frequently Asked Questions

Q. What is sarcoidosis of the lungs?

Pulmonary sarcoidosis is an inflammatory disease in which the immune system forms clusters of cells called granulomas in the lungs and surrounding lymph nodes. These granulomas can impair lung function over time. The condition is systemic — it can affect other organs — but the lungs are involved in over 90% of cases. The exact trigger is unknown; current evidence points to an abnormal immune response to an environmental or microbial factor in genetically susceptible individuals.

Q. What are the symptoms of pulmonary sarcoidosis?

Common symptoms include a persistent dry cough, breathlessness on exertion, chest tightness, fatigue, low-grade fever, and unintentional weight loss. Some patients have no symptoms at all and are diagnosed incidentally on a chest X-ray. Skin rashes (erythema nodosum), red or painful eyes, and swollen lymph nodes in the neck may also appear alongside respiratory symptoms and should prompt specialist evaluation.

Q. Can sarcoidosis be confused with tuberculosis in India?

Yes. Sarcoidosis and tuberculosis share many clinical and radiological features — both can cause bilateral hilar lymphadenopathy, fever, weight loss, and cough. In India, where TB is prevalent, sarcoidosis is frequently misdiagnosed as TB. Key differentiators include a negative tuberculin test or IGRA, elevated serum ACE, and histology showing non-caseating granulomas on biopsy. EBUS-guided lymph node biopsy is the preferred minimally invasive method for tissue confirmation.

Q. Does sarcoidosis go away on its own?

In many patients — particularly those with Stage I or Stage II disease and mild symptoms — sarcoidosis does remit spontaneously without treatment. However, a proportion of patients develop chronic or progressive disease requiring long-term therapy. Regular monitoring with pulmonary function tests and imaging is essential even in patients under observation, as disease can progress silently. A pulmonologist should guide the decision on whether to treat or observe.

Q. What treatment is recommended for pulmonary sarcoidosis?

Treatment depends on disease stage and severity. Patients with mild or no symptoms may be monitored without medication. Those with significant symptoms, declining lung function, or Stage III–IV disease are typically treated with oral corticosteroids (prednisolone) as first-line therapy. Steroid-sparing agents such as methotrexate or azathioprine are used when steroids are not tolerated or when long-term therapy is needed. Pulmonary rehabilitation supports functional recovery alongside medical treatment.

Q. How is sarcoidosis diagnosed at Pulmo Vista in New Delhi?

Diagnosis involves chest X-ray and HRCT imaging, pulmonary function tests, bronchoscopy with bronchoalveolar lavage, and — most importantly — tissue biopsy showing non-caseating granulomas with tuberculosis excluded. EBUS (endobronchial ultrasound) is the preferred minimally invasive method for obtaining lymph node tissue. Serum ACE levels and tuberculin skin tests or IGRA are used as supportive investigations. All these investigations are available at Pulmo Vista, Greater Kailash, New Delhi.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top